Clinical research of kidney diseases V: Extended analytic models

Nephrology Dialysis Transplantation

Volumn 23, Issue 5, 2008, Pages 1484-1492

  Ravani, Pietro ^a,b,c   Parfrey, Patrick ^b   Gadag, Veeresh ^b   Malberti, Fabio ^a   Barrett, Brendan ^b  

^a CREMONA HOSPITAL   (Italy)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c Divisione di Nefrologia e Dialisi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF COVARIANCE; ANALYTIC METHOD; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL RESEARCH; CORRELATION ANALYSIS; DATA ANALYSIS; ECHOCARDIOGRAPHY; ENVIRONMENTAL EXPOSURE; KIDNEY DISEASE; OUTCOME ASSESSMENT; POISSON DISTRIBUTION; PRIORITY JOURNAL; RADIAL ARTERY; REVIEW; STATISTICAL MODEL; SURVIVAL; SURVIVAL TIME;

ANALYSIS OF VARIANCE; DATA INTERPRETATION, STATISTICAL; HUMANS; KIDNEY DISEASES; LINEAR MODELS; MODELS, STATISTICAL; RESEARCH DESIGN; RISK; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 44449112641     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn138     Document Type: Review

References (25)

1. Ravani P, Parfrey P, Gadag V et al. Clinical research of kidney diseases III: principles of regression and modelling. Nephrol Dial Transplant 2007; 22: 3422-3430
2. Ravani P, Parfrey P, Murphy S et al. Clinical research of kidney diseases IV: standard regression models. Nephrol Dial Transplant 2008; 23: 475-482, NDT Advance Access published on January 8, 2008
3. Schrier R, McFann K, Johnson A et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol 2002; 13: 1733-1739
4. West B, Welch K, Galecki AT. Linear mixed models: an overview. Linear Mixed Models: A Practical Guide Using Statistical Software. New York: Chapman & Hall/CRC, 2007, 9-49
5. Freedman BI, Langefeld CD, Lohman KK et al. Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. J Am Soc Nephrol 2005; 16: 2156-2161
6. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84: 1074-1078
7. White H. Maximum likelihood estimation of misspecifed models. Econometrica 1982; 50: 1-25
8. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130
9. Therneau TM, Grambisch PM. Multiple events per subject and frailty models. Modeling Survival Data: Extending the Cox Model. New York: Springer, 2000, 159-260
10. Lee EW, Wei LJ, Amato D. Cox-type regression analysis for large number of small groups of correlated failure time observations. Survival Analysis, State of the Art. The Netherlands: Kluwer, 1992, 237-247
11. Ravani P, Tripepi G, Malberti F et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 2005; 16: 2449-2455
12. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84: 1065-1073
13. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524-532
14. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stat 1982; 10: 1100-1120
15. Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika 1981; 68: 373-379
16. Huang X, Wolfe RA. A frailty model for informative censoring. Biometrics 2002; 58: 510-520
17. Box-Steffensmeier JM, De Boef S. Repeated events survival models: the conditional frailty model. Stat Med 2006; 25: 3518-3533
18. Liu L, Wolfe RA, Huang X. Shared frailty models for recurrent events and a terminal event. Biometrics 2004; 60: 747-756
19. Mahe C, Chevret S. Analysis of recurrent failure times data: should the baseline hazard be stratified? Stat Med 2001; 20: 3807-3815
20. Eknoyan G, Beck GJ, Cheung AK et al. Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
21. Ravani P, Tripepi G, Pecchini P et al. Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney Int 2008; 73: 95-101
22. Dittrich E, Puttinger H, Schillinger M et al. Effect of radio contrast media on residual renal function in peritoneal dialysis patients - a prospective study. Nephrol Dial Transplant 2006; 21: 1334-1339
23. van Vilsteren MC, de Greef MH, Huisman RM. The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant 2005; 20: 141-146
24. Weijnen TJ, van Hamersvelt HW, Just PM et al. Economic impact of extended time on peritoneal dialysis as a result of using polyglucose: the application of a Markov chain model to forecast changes in the development of the ESRD programme over time. Nephrol Dial Transplant 2003; 18: 390-396
25. Espinosa M, Martn-Malo A, Ojeda R et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004; 43: 685-689